Hadar Levy - 18 Mar 2026 Form 3 Insider Report for Brainsway Ltd. (BWAY)

Role
Chief Executive Officer
Signature
/s/ Hadar Levy
Issuer symbol
BWAY
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 16:03:38 UTC
Previous filing
07 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Levy Hadar Chief Executive Officer 16 HARTUM STREET, RAD TOWER, 14TH FLOOR, HAR HAHOTZVIM, JERUSALEM, ISRAEL /s/ Hadar Levy 18 Mar 2026 0001943548

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BWAY Ordinary Shares 123,050 18 Mar 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BWAY Stock Options (right to buy) 18 Mar 2026 Ordinary Shares 80,000 Direct F1, F3, F4
holding BWAY Stock Options (right to buy) 18 Mar 2026 Ordinary Shares 62,500 Direct F1, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 This figure includes: (i) 16,800 ordinary shares and (ii) unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 31,250 ordinary shares vesting in equal quarterly installments until March 5, 2028 and (b) RSUs to receive 75,000 ordinary shares vesting in equal yearly installments until March 9, 2029, subject to certain vesting conditions.
F3 Stock options were granted on February 9, 2023, with the remaining options to purchase 80,000 ordinary shares vesting in equal quarterly installments until February 13, 2027, with acceleration in the event of a change of control.
F4 The exercise price is NIS 3.65 per share.
F5 Stock options were granted on March 5, 2024, with the remaining options to purchase 62,500 ordinary shares vesting in equal quarterly installments until March 5, 2028.
F6 The exercise price is NIS 11.17 per share.